•
Dec 31, 2022
The Joint Q4 2022 Earnings Report
The Joint Corp. reported a strong Q4 2022 with revenue growth, reflecting a greater number of franchised and corporate clinics and continued organic growth.
Key Takeaways
The Joint Corp. reported a revenue of $27.8 million for Q4 2022, a 26% increase compared to Q4 2021. The company's operating income increased to $1.3 million, and net income was $547,000, or $0.04 per diluted share. The company increased clinic count to 838 at year-end 2022, including 126 company-owned or managed clinics.
Revenue increased to $27.8 million, up 26% compared to Q4 2021.
Operating income was $1.3 million, compared to $7,000 in Q4 2021.
Net income was $547,000, or $0.04 per diluted share, compared to a net loss of $360,000 in Q4 2021.
Adjusted EBITDA was $4.0 million, compared to $2.1 million in Q4 2021.
The Joint
The Joint
Forward Guidance
Management provided financial and clinic opening guidance for 2023 and will continue to acquire previously franchised clinics.